16 Minutes on the News is a short news podcast where we cover the top headlines of the week, the a16z podcast way -- why are these topics in the news; what's real, what's hype from our vantage point; and what are our experts' quick takes on these trends?
About the a16z Podcast: Discusses tech and culture trends, news, and the future -- especially as ‘software eats the world’. It features industry experts, business leaders, and other interesting thinkers and voices from around the world. This podcast is produced by Andreessen Horowitz (aka “a16z”), a Silicon Valley-based venture capital firm. Multiple episodes -- and now shows -- are released every week; visit a16z.com for more details and to sign up for our newsletters and other content as well!
112 Subscribers
Podcast hosts
No host has claimed this podcast yet, if you are the host you can verify ownership by claiming this podcast
Keywords
© 2019 Andreessen Horowitz
16 Minutes News by a16z
Read more
112 Subscribers
Reviews
4 out of 5 stars
Based on 3 reviews
BaglanS
2 out of 5 stars
Episode 69. Stop breathing into the mic
Super annoying that the host mic is not set up properly with too much noise when speaking. Also annoying to hear his breathing while the guest is speaking.
NYC2Europe
5 out of 5 stars
Fantastic news resource // smart and deep
Please keep it up! Excellent way to keep up with news. Great achievement. Sonol is a total QUEEN!
fndoz
5 out of 5 stars
Outside of the mainstream, good production
This is a good show. Keep it up!
Podcast information
- Amount of episodes
- 71
- Subscribers
- 112
- Verified
- No
- Website
- Explicit content
- No
- Episode type
- episodic
- Podcast link
- https://podvine.com/link/..
- Last upload date
- February 22, 2022
- Last fetch date
- October 2, 2022 4:17 AM
- Upload range
- WEEKLY
- Author
- Andreessen Horowitz
- Copyright
- 2019 Andreessen Horowitz
susbcribers
- Parasite, the Malaria (Tech & Science) Editionoriginal episode notes and transcript here: https://future.a16z.com/podcasts/malaria-vaccine-tech-science-news/ Longtime podcast showrunner (2014-2022), primary host, and editor Sonal Chokshi shares three best-of episodes as she shifts gears and the show goes on hiatus until relaunched with a new host. As with all of the episodes on this show about tech & science trends in the news, and where they are on the long arc of innovation -- this one is actually a story of human ingenuity over 100 years in the making, with the ultimate breakthrough in a malaria vaccine just last year that we discuss here. (And while we were one of the very first to cover the coronavirus pandemic back in Jan 2020, and several episodes all about vaccines, this is an unusual one: fighting a parasite vs a virus, what that means, how, and why it matters.) It is also one of Chokshi's signature “2x explainers”, where we quickly cover the headlines and tech trends, but also offer evergreen explainers, analysis, frameworks, and more to understand those trends -- whether it was TikTok’s algorithm, GPT-3, the opioid crisis, or the anatomy of a hack. Thank you to you all for listening, sharing, engaging and coming along with us on this journey! Thank you as well to our brilliant audio editors, expert guests, and several others. The team will be putting this feed on hiatus temporarily, and in the meantime, you can follow my other work here at a16z as well as other projects on Twitter @smc90. Stay tuned for more!0 comments0
- Crypto at Congress: 'Watershed' Moment for Regulation and Web3Welcome to 16 Minutes, our podcast where we discuss tech trends in the news and their impact on the long arc of innovation. Today’s topic is crypto regulation, and specifically, two recent federal government hearings in the news that were focused on crypto and therefore the related trend of web3. In contrast to the model of web2 — typified by very broadly used but also very centralized platforms run by corporations — web3 refers to the idea of a new internet enabled by crypto that is owned by builders and users. The first hearing that took place was at the House Committee on Financial Services, featuring six crypto company CEOs and resulting in a five-hour session that prompted headlines like “Congress Gets a Crash Course on Cryptocurrency.” Then, just last week, the U.S. Senate’s Banking, Housing, and Urban Affairs Committee held its own hearing, this time focused on stablecoins, which are privately issued cryptocurrencies that are pegged to a stable asset such as the U.S. dollar, and are used in decentralized financial services. We’ve covered crypto regulatory issues on 16 Minutes before with a16z experts, including an episode with former federal prosecutor Katie Haun and former New York Stock Exchange regulatory chief Anthony Albanese. That discussion, which you can find in this feed under episode #50, was about a proposal by the Treasury Department’s financial crimes enforcement arm that included provisions for digital asset reporting. (As a reminder, none of the following should be taken as investment advice, please see a16z.com/disclosures for more important information.) All of these hearings are also connected to the broader question of innovation, and keeping the U.S. competitive on a global stage. So with that context, our guest today is a16z global head of policy Tomicah Tillemann, who before joining a16z served as senior advisor to two secretaries of state. He reports on the hearings and their significance, and gives a quick pulse-check on where we are with crypto regulation right now.0 comments0
- Inside the GameStop Drama; The U.S. Constitution, AuctionedWelcome to 16 Minutes, our show on the a16z podcast network where we talk about tech trends that are dominating news headlines, industry buzz, and where we are on the long arc of innovation. Today’s episode actually features a look back at the GameStop saga — the stock market drama that some headlines described as a “David-and-Goliath battle” that quote “ upended Wall Street. ” For quick basic context, here’s what happened: A group of Reddit users mass-purchased and drove up prices of stock in the video game retailer GameStop, forcing short sellers including hedge funds and institutional investors to back out in a short squeeze, pushing prices even higher. But beyond the news, this also portended other, broader trends including redefining the power of retail investors, the phenomenon of meme stocks, and more. So in this episode — which is from a conversation that originally took place live on Clubhouse (and which, by the way, can also be found on the a16z Live feed) — a16z co-founder Marc Andreessen talks to Ken Griffin, founder and CEO of the hedge fund Citadel, which was a key player in GameStop as both a market maker and investor. You’ll also hear a16z general partner and fintech expert Alex Rampell join later in the conversation. Griffin also just purchased (in a Sotheby’s auction a little over two weeks ago) one of the original copies of the U.S. Constitution, an auction in which a decentralized autonomous organization called ConstitutionDAO also bid on buying it. Marc and Ken touch briefly on this at the very end.0 comments0
- Steam Halts Web3 Games; FDA Approves Prostate Cancer AIWelcome to 16 Minutes, our show where we talk about tech trends in the news. We have two segments today: 1) The announcement recently that Valve Software, which operates the massive gaming platform Steam, added a rule against games that use blockchain technologies or that allow users to exchange cryptocurrencies or NFTs – this rule appeared on its “What you shouldn’t publish on Steam” onboarding list for developers. We go beyond the players to the trends at play here, putting the news in context — as is the premise of this show — because it not only immediately impacts gaming developers and gamers using the platform, but has implications for gaming business models and the arc of innovation in gaming as part of the web3 movement. Our expert guests are a16z partner Jonathan Lai and a16z partner Eddy Lazzarin. 2) The FDA’s announcement last month that it authorized marketing of the “first artificial intelligence (AI)-based software designed to identify an area of interest on the prostate biopsy image with the highest likelihood of harboring cancer so it can be reviewed further by the pathologist if the area of concern has not been identified on initial review.” The FDA reviewed the technology from Paige Prostate through its De Novo regulatory pathway. We have three expert guests: Eli Van Allen, associate professor of Medicine at Harvard Medical School and chief of the Division of Population Sciences at the Dana-Farber Cancer Institute; a16z bio general partner Vineeta Agarwala; and a16z bio partner Jay Rughani.0 comments0
- mRNA for Flu Vaccine? AI Protein-Folding Goes Open SourceIn today’s episode we have two short segments, both on bioscience topics: [0:00] Moderna has started clinical trials for a flu vaccine, called mRNA-1010, that is based on the same mRNA technology that Moderna and Pfizer used for their COVID vaccines, and that several other companies including Sanofi and Glaxo all are actively working on for the influenza use case. Our experts are general partners Vineeta Agarwala and Jorge Conde of the a16z bio team, who have joined us on many of our vaccine-related episodes, which you can find at a16z.com/vaccines. They discuss what comes next for the clinical trials of this mRNA-based flu vaccines, why companies aren't planning to use the faster and more-targeted mRNA technology for COVID's Delta variant, and how mRNA vaccines will change not only our approach to flu shots but to other respiratory viruses. [9:53] Google’s DeepMind AlphaFold, in partnership with the European Molecular Biology Laboratory, is publicly sharing its entire protein structure database -- with predicted protein structure models for ~20,000 proteins expressed by the human genome -- meaning that all its data will be freely and openly available to the scientific community. (We previously discussed DeepMind's AlphaFold protein-folding AI on this show in episode #48.) General partner Vijay Pande of the a16z bio team helps us answer the question: Why does it matter that a huge database of very accurate predicted protein structures is now freely available?0 comments0
- Opioid Crisis - How, Who, and TechGiven recent news of drug company settlements, calls to action, policy moves, and more, this episode is a rerun of one of our very early explainers (episode #4 of 16 Minutes, 2019) on the opioid crisis. Bio experts and a16z general partners Jorge Conde and Vijay Pande discuss on 16 Minutes (our shortform show where we discuss the headlines, tease apart what's hype' what's real, and where we are on the long arc of innovation) with host Sonal Chokshi: how opioids work; the questions around who's to blame; and other directions for managing pain. Where could tech come in, even with the broader social, cultural, and structural context involved here? original episode: https://a16z.com/2019/08/04/16mins-news-opioid-crisis-dea-database/0 comments0
- Ransomware Attacks on the Rise; Hackers Target IoTWelcome to 16 Minutes, the a16z show where we talk about tech trends in the news, what’s hype and what’s real, and the long arc of innovation. In today's episode we’re talking about the latest developments and trends in cybercrime – including the trends of ransomware, and, attacks on physical infrastructure. First (0:00 - 6:07), we have the recent attack on the meat processing plant JBS, the largest meat processor in the world; just last week it had to temporarily shut down some operations in the U.S., Canada, and Australia due to an attack on its servers, with the hackers demanding payment from the company. These types of “ransomware" attacks are increasing – recently hackers hit the Colonial Pipeline, the largest refined oil pipeline in the U.S., and disrupted fuel distribution on the East Coast. In that attack, hackers demanded and received millions in ransom, though the Justice Department announced on Monday it had recovered much of that ransom, paid in bitcoin. Hackers have also recently hit health care organizations, school systems, and even ferry services. In the second segment (6:08 - 12:13), we’ll briefly talk about the breach of home and enterprise wireless network management technology provider Ubiquiti. Security researcher Brian Krebs reported allegations from a whistleblower, and more recently, lawsuits have been filed. Here we’ll focus on the questions it raises for security. Both segments feature a16z operating partner for security (and former Box CSO) Joel de la Garza. Martin Casado, a16z general partner and co-founder of networking company Nicira, joins us for the second segment. ### The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, this content may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets) is available at https://a16z.com/investments/. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.1 comments1
- Science (and Tech), the Endless FrontierGiven recent buzz and ongoing debates around the Endless Frontiers Act -- which some have described as “the most important piece of legislation no one's heard of” -- this episode is a rerun of an episode from last year, recorded after said act was initially unveiled. The short discussion covers the broader topic and theme of funding science and innovation, and R&D in general -- not just in government agencies, but corporations, and the overall landscape there as well. Notably, the name of the Endless Frontiers act was inspired by the famous memo, “ Science, the Endless Frontier ”, which was a report to the then U.S.-President by Vannevar Bush, Director of the Office of Scientific Research and Development in July 1945 -- and that led to the creation of the independent government agency the National Science Foundation (NSF). For quick context (without covering current discussions/ updates in the news right now) -- the bipartisan proposal had proposed giving NSF over $100B over 5 years in funding. It had also proposed rebranding the National Science Foundation into the National "Science and Technology" Foundation, which a16z general partner Martin Casado (who has worked the full spectrum from academia to research lab to startup to big company) discusses with Sonal Chokshi in this episode. You can also find their conversation with former Stanford president John Hennessy and Marc Andreessen on the changing relationship between academia and industry at a16z.com/researchtostartup. original episode: https://a16z.com/2020/07/09/16mins-nsf-funding-science-corporate-innovation-remote-work-new-normal-future/0 comments0
- Malaria Vaccine Breakthrough, Beyond the BuzzPlaying out against the backdrop of a global pandemic (including recent massive surges in regions around the world) is the news that came out a week ago that a candidate "malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal”. While the findings are still in preprint with The Lancet, the resulting buzz and phrases quoted included everything from “unprecedented”, “groundbreaking work”, and “very exciting” to “high expectations”, “highly effective”, and “a hugely significant extra weapon”... A "weapon" in the war against malaria that is -- a disease that is estimated to cause over 400,000 deaths each year globally, and predominantly in children under the age of five. So in this special 2x explainer episode of 16 Minutes (also running on the a16z Podcast), we -- Rajeev Venkayya of Takeda Pharmaceuticals, a16z bio general partner Jorge Conde, and Sonal Chokshi -- dig into what's hype/ what's real about this news, beyond the headlines and beyond the buzz. What does the data tell us, what does the current study phase mean, and what's left to get to widespread, real-world use? How does this candidate vaccine (R21 from Jenner Institute/ Oxford University) compare to the other malaria vaccine (RTS,S from GlaxoSmithKline)? How do, and don't, advances in and around COVID vaccines play here? And why has it been so hard to develop vaccines for this particular disease? Because we also cover (as is the premise of the show) where we are on the long arc of innovation... and this is an innovation story that's been nearly a century in the making.3 comments3
- Apple Event: Desktop-Tablet Convergence, Cord-Cutting, "Find Anything," & MoreIn this week’s episode of 16 Minutes, our show where we cover tech trends in the news — and also cover themes from company developer and innovation events! — we focus on the latest coming out of Apple’s event this week. The company announced a bunch of things, ranging from new device colors and form factors to podcast services, but in this episode we asked regular guest Steven Sinofsky (an a16z board partner and former Microsoft Windows president who has appeared on past event episodes including covering CES and Apple’s M1 chip) to weigh in. He shares what he thinks all these moves say about the evergreen “consumer vs. professional” question, to what the company’s new devices (namely tablets, personal computers, and TVs) tell us about the long arc of innovation.0 comments0
- J&J Vaccine Pause; FBI Accesses Servers in Exchange HackWe have two brief segments in today’s episode: News and analysis of the Johnson & Johnson COVID vaccine pause, and the widespread hack of Microsoft Exchange Servers across the country (and the dramatic and unusual steps the FBI took in response). Johnson & Johnson: Federal health officials last week revealed that six women who received the vaccine had developed rare and severe blood clots in their brain, in one case fatally. Even more recently, a panel of expert advisors to the Centers for Disease Control determined that they needed more time to assess the risk of the drug, which was approved by the FDA under Emergency Use Authorization, or EUA. Our experts are General Partner Jorge Conde, who previously appeared on a episode on J&J efficacy rates, and General Partner Vineeta Agarwala, who is also a practicing clinician at Stanford Hospital, and recently joined us on "16 Minutes" with Dr. Bob Wachter of UCSF to analyze the vaccine rollout in the U.S. They address the clinical facts about the six J&J cases (and contrast it to the social media conversations and headlines), the incidence rate, and what the J&J vaccine shares with the Astra Zeneca vaccine, which has been halted or limited in Europe and elsewhere over similar blood clot concerns. FBI and Microsoft Exchange Servers: The Department of Justice recently announced that the FBI, after getting court authorization, had removed malicious code from hundreds of computers running on-premises versions of Microsoft Exchange Server software used to provide email services. In March, Microsoft had announced the initial hack and released detection tools and patches to help owners of the compromised computers, but the latest government announcement revealed that the FBI had taken the step of removing the malicious code, in this case web shells that enable remote administration, from computers that had not mitigated the risk. Microsoft has associated the hackers with state-sponsored actors in China. Our expert is a16z's Joel de la Garza, who explains what’s behind this unusual action and figure out where it fits into larger trends of enterprise security and even national security. ### The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, this content may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets) is available at https://a16z.com/investments/. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.0 comments0
- NFTs: What, Where, How, Why, WhoThis deep-dive -- one of our occasional 2-4X explainer episodes on 16 Minutes; (past such episodes have covered everything from Section 230 and Tiktok to GPT-3 and the opioid crisis) -- teases apart what's hype/ what's real -- and the what, where, how, why, who, and other questions top of mind around all things NFTs: what NFTs (non-fungible tokens) are -- as well as the properties of crypto that enable them, just to set some big-picture context; what forms they take, and what is and ISN’T an NFT -- including where “social tokens” and the creator economy do and don’t come in; common myths and misconceptions -- from ‘just a jpg’ to the frequent question of energy use & NFTs; how they work -- as well as the broader ecosystem around NFTs, and different players; various applications, now and next -- touching briefly on how to think about NFTs, whether you’re an artist/ creator, developer, or institution. Editor in chief Sonal Chokshi interviews friends of a16z crypto Linda Xie, co-founder of Scalar Capital and former Product Manager at Coinbase; and Jesse Walden, founder at Variant Fund and former co-founder of Mediachain Labs (which was acquired by Spotify, where he was then an R&D lead). Posted on both the a16z Podcast show and 16 Minutes, this episode is for everyone! transcript available at: https://a16z.com/2021/03/27/nfts-explainer-faqs-hype-reality-innovation-crypto-creator-economy The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, this content may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets) is available at https://a16z.com/investments/. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.0 comments0
- The U.S. Vaccine RolloutToday on our news analysis show 16 Minutes — since this show is all about teasing apart what’s hype/ what’s real and where we are on the long arc of innovation — we're taking a quick pulse-check with the experts on just where we are with the COVID vaccine rollout in the U.S. Our experts today are Dr. Bob Wachter, the Chair of the Department of Medicine at UCSF — he has come to additional prominence during the pandemic as a regular public resource, providing daily updates & reports on Twitter throughout the crisis. He’s also currently guest-hosting the “In the Bubble” podcast. We also have Dr. Vineeta Agarwala, a general partner in a16z bio who is also a practicing clinician at Stanford Hospital. You can catch our ongoing coverage of all things vaccines at a16z.com/vaccines. But in this episode we cover where we really are right now with the vaccine rollout — is it working or not, given all the buzz and mixed messages we’ve been hearing on social and in the media? We cover everything from distribution, in practice (that is, from the clinical/ on-the-ground perspective); to other dynamics (such as new strains), to demand for the vaccines (including vaccine hesitancy, and it's not just about anti-vaxxers); to the data (which is where we start). On Friday the CDC reported that about 77 million people in the U.S. have currently received at least one dose of a COVID vaccine, with about 42 million who have been fully vaccinated.0 comments0
- The Johnson & Johnson Vaccine and COVID Efficacy RatesIn today's episode of our news analysis show 16 Minutes, our topic is the ongoing buzz and the mixed news around the Johnson & Johnson vaccine, which was the third vaccine for COVID approved under Emergency Use Authorization by the FDA just a few weeks ago. Johnson & Johnson reported it as “the first single shot vaccine” and as having 85% efficacy in preventing severe disease across regions studied; meanwhile, STAT headlines reported 66% efficacy overall and 72% in the U.S. in preventing moderate to severe disease, calling it “a weapon but not a knockout punch.” And then we have various experts saying everything from “disappointing” to pointing out the dangers of comparing this vaccine to other vaccines such as Pfizer’s and Moderna’s, both of which we’ve talked about on this show. You can find all our ongoing vaccines coverage at a16z.com/vaccines. In this episode — since 16 Minutes is about teasing apart what’s hype/ what’s real in the news and where we are on the long arc of innovation — we asked the a16z bio team for their frameworks. Joining us are General Partner Jorge Conde, who has been in all our vaccine episodes and previously led strategy and product for a pharmaceuticals company, and bio editorial partner Lauren Richardson, who was previously an editor at PLOS Biology and hosts our sister show Journal Club on Bio Eats World. She also holds a Ph.D in pharmacology.0 comments0
- Semiconductor Shortage and the Global Supply Chain SqueezeIn this week’s episode of 16 Minutes, our show where we talk about tech trends in the news, what’s hype/ what’s real, and where we are on the long arc of innovation, the topic is semiconductors – specifically, the ongoing global shortage that began last summer and has intensified in recent weeks. So much so, that the U.S. president signed an executive order just last week to address concerns around the shortage, calling for reviews of supply chains for critical sectors of the economy. Our expert is a16z Operating Partner Frank Chen, who led our research arm and has also joined past episodes about semiconductors on this show including one with Steven Sinofsky and Sonal in which they analyzed the ARM and Envidia news. Frank joins a16z's Zoran Basich to cover the bigger picture of the chip shortage including geopolitics, the pandemic, and several other factors — all in almost exactly 16 minutes!0 comments0
- When Christie's Meets Crypto — The NFT MomentIn this week’s episode of 16 Minutes — where we talk about tech trends in the news, what’s hype/ what’s real, and where we are on the long arc of innovation — the topic is NFTs ("non-fungible tokens"); specifically, the news that Christie’s has become the first major auction house to offer a purely digital artwork tied to an NFT or “non-fungible token." We’ll go more into NFTs (as well as whether this is really a big deal or not) in this episode, but here’s the news context: The work of art being auctioned is a digital collage by the digital artist Beeple; it’s called Everydays: The First 5,000 Days. The Christie’s auction begins today and runs through March 11. It's news because Christie's, a 250-year-old auction house, is an established presence in the traditional art marketplace, and it’s the first time NFTs (which have been much-buzzed-about in the crypto world for several months) are being formally embraced by the traditional art world. For quick context, NFTs are digital tokens on the Ethereum blockchain, which allow art and other digital assets and collectibles to be verified as unique, hence the term non-fungible (as compared to other, more fungible tokens). They reflect the properties of crypto and blockchains more broadly, such as the ability to track provenance and attribute funds to creators via smart contracts. (For more discussion of NFTs and related themes, check out our previous podcasts Crypto for Creators: From Art Galleries to 'Tokenized' Collectibles and The New Fan Club: Creators, Fans, and the Power of Markets (& Crypto). Zoran Basich of a16z talked to NFT expert Kayvon Tehranian, CEO and founder of Foundation Labs, a marketplace for digital art and collectibles, to help us dig into the Christie's news and broader trend — all in less than 16 Minutes! *** The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, this content may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets) is available at https://a16z.com/investments/. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.0 comments0
- China Steams Ahead in Gaming; MetaHuman Creator and the Uncanny ValleyWe have two brief segments — taking up less than 16 Minutes! — in this week’s episode of "16 Minutes," where we talk about tech trends in the news, what’s hype/what’s real, and where we are on the long arc of innovation. Both segments touch on trends in gaming/ online worlds and entertainment — both now and "next." First, Steam China: Steam — the cloud library and marketplace for buying, selling, and storing games that was launched by Valve in 2003 and is now the largest distribution platform for PC gaming — just released an official Chinese version. Next, Meta Human Creator: Epic Games’ 3D graphics platform Unreal Engine revealed an early peek at a new content creation tool that aims to make creating digital humans easier. So what does this all mean? We talked to a16z partner Jonathan Lai, a former product manager at Riot Games, who joins 16 Minutes co-host Zoran Basich for both segments to share a quick take on these news items and the trends overall.0 comments0
- Beyond Bezos: Amazon, Cloud, and CEO TransitionsAmazon just announced this week that its founder and CEO Jeff Bezos "will transition to the role of Executive Chair in the third quarter of 2021 and [CEO of Amazon Web Services] Andy Jassy will become Chief Executive Officer at that time". So in this episode of 16 Minutes -- our show where we talk about tech trends in the headlines, what's hype/ what's real, and where we are on the long arc of innovation -- we talk not just about this news, but what it signals regarding cloud computing as well as CEO transitions in general. How does/ doesn’t it fit into other patterns of tech succession -- like recent moves at Netflix (where Chief Content Officer Ted Sarandos was named co-CEO alongside Reed Hastings); Microsoft (Satya Nadella); Intel (Pat Geisinger); Cisco and more? Is Amazon -- with its ability to straddle both enterprise and consumer so strongly -- an outlier, and perhaps more of a conglomerate? And are there certain inflection points or phases for when companies of all sizes should think about succession planning/ such leadership transitions? Sonal Chokshi and Zoran Basich chat with a16z general partner Martin Casado -- who was previously cofounder and CTO at Nicira (which was acquired by VMware, where he became GM of the Networking and Security Business Unit) -- so Casado knows a thing or two about such transitions... not to mention his own past debates and discussions of whether or not to bring on an external CEO. The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, this content may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets) is available at https://a16z.com/investments/. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.0 comments0
- Anatomy of a Hack: SolarWinds and Ripples BeyondIn this special “3x”-long episode of our (otherwise shortform) news analysis show 16 Minutes -- past such 2-3X explainer episodes have covered section 230, Tiktok, GPT-3, the opioid crisis, more -- we cover the SolarWinds hack, one of the largest (if not the largest!) publicly known hacks of all time... and the ripple effects are only now starting to be revealed. Just this week, the U.S. Cybersecurity and Infrastructure Security Agency shared ( as reported in the Wall Street Journal) that approximately 30% of both private-sector and government victims linked to the hack had no direct connection to SolarWinds. So who was compromised, do they even know, can they even know?! Because this hack is a supply-chain compromise involving various third-party software and services all connected together in a "chain of chains", the knock-on effects of it will be revealed (or not!) for years to come. So what do companies -- whether large enterprise, mid-sized startup, or small business -- do? What actually happened, and when does the timeline really begin? While first publicly revealed in December 2020 -- we first covered the news in episode #49 here when it first broke, and there have been countless headlines since (about early known government agency victims, company investigations, other tool investigations, debates over who and how and so on) -- the hack actually began not just a few months but years earlier, involving early tests, legit domains, and a very long game. We help cut through the headline fatigue of it all, tease apart what's hype/ what's real, and do an "anatomy of a hack" step-by-step teardown -- the who, what, where, when, how; from the chess moves to technical details -- in an in-depth yet accessible way with Sonal Chokshi in conversation with a16z expert and former CSO Joel de la Garza and outside expert Steven Adair, founder and president of Volexity. The information security firm (which specializes in incident response, digital forensics/ memory analysis, network monitoring, and more) not only posted guidance for responding to such attacks, but also an analysis based on working three separate incidents involving the SolarWinds hackers. But how did they know it was the same group? And why was it not quite the perfect crime? image: Heliophysics Systems Observatory spacecraft characterize, in the highest cadence, the constant stream of particles exploding from the sun affect Earth, the planets, and beyond via NASA Goddard Space Flight Center / Flickr0 comments0
- Dall-E AI for Images; Direct Listings, SEC Ruling for Issuing SharesWe've got segments on artificial intelligence and IPO innovation in today's episode of 16 Minutes, where we take a look at the news and what it means for the long arc of innovation. In the first segment (0:00) : Take the surrealistic images of Salvador Dali and cross them with Pixar's animated film Wall-E and you've got ... Dall-E! It's a new neural network that creates images based on text inputs, and the worlds of A.I. and machine learning recently got their first glimpse. Last summer, research lab OpenAI released an API for the machine learning model GPT-3, which caused a stir with the way it could produce text that was hard to distinguish from human writing (16 Minutes showrunner Sonal Choksi and a16z Operating Partner Frank Chen discussed it in a recent 16 Minutes Podcast, "GPT-3: Beyond the Hype," breaking down what it does and doesn't mean for startups, incumbents, and the idea of "AI as a service"). Now OpenAI has unveiled Dall-E, which processes language to create new images (not new text, as GPT-3 does). Dall-E does this using a neural network called CLIP (Contrastive Language-Image Pre-training), which classifies a wide variety of images culled from the internet while "filling in the blanks" using zero-shot reasoning, enabling Dall-E to produce surprising images by inferring information it wasn't trained in. We called on Frank again to explain where Dall-E (and the broader topic of machine learning) sits on the path toward artificial general intelligence (AGI), how Dall-E's transformer-type architecture is able to infer information, what its limitations might be, and what uses we might see as this technology develops. -- with Zoran Basich In the second segment (12:58), we had a quick chat with a16z operating partner Scott Kupor about the recent decision by the SEC to allow the issuance of new shares via direct listings on the New York Stock Exchange. Previously direct listings were limited to the sale of existing shares. Recent first-day IPO "pops" have sparked much discussion about the fairness or unfairness of the process and whether the current path we have for companies going public is broken or just needs some tinkering around the edges. Scott breaks down how the new rule will affect companies, as well as institutional and retail investors, and what this means in the long arc of IPO innovation. -- with Zoran Basich The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, this content may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets) is available at https://a16z.com/investments/. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.0 comments0
- All about Section 230, In the NewsAll about section 230 of the Communications Decency Act -- what does and doesn't it say? How does this law play out against broader questions and debates around platforms, content moderation, and free speech? This conversation between Mike Masnick (founder and editor in chief of Techdirt) and a16z editor in chief Sonal Chokshi was originally published May 2020, in the context of previous protests and presidential tweets (and an executive order then to prevent “online censorship”)-- but is exactly as relevant today... perhaps now more than ever. https://a16z.com/2020/05/31/16mins-section-230-communications-decency-act-content-moderation-free-speech-internet-past-present-future/ image: presidential tweet activity/ Wikimedia Commons0 comments0
- FinCEN Crypto Rule; Haven Healthcare BreakupWe're covering two trends in this week’s episode of "16 Minutes," where we talk about the news, tech trends, and the long arc of innovation: #1 FinCEN, the Treasury Department's financial crimes enforcement arm, proposed a new rule targeting cryptocurrency holders’ ability to transact using self-hosted wallets. These are software applications for storing crypto that allow people to transact on the blockchain directly, rather than going through financial institutions. The rule would require banks and other financial businesses to keep records, and verify the identities not only of their customers but also — notably — their customers’ counterparties, or people with whom the customer transacts, in certain cases. (Full disclosure: a16z has publicly opposed this plan, and has said it plans to join others in the industry in challenging the rule in court. You can read more about our position here.) a16z General Partner Katie Haun and Operating Partner Anthony Albanese explain the rule and what impact it could have on crypto innovation. #2 Amazon, Berkshire Hathaway, and JP Morgan Chase shut down their joint healthcare venture. Haven was touted as a potential game-changer for employee-funded health care plans and health costs in general, due to the combined resources of its three corporate sponsors, but it was disbanded after three years. We turn to a16z bio General Partner Julie Yoo for a quick check-in on what opportunities this project actually highlighted (including for startups). — with Zoran Basich0 comments0
- U.S. Government Hacked; Scaling EthereumWe're back to covering multiple items on our show 16 Minutes -- which covers the news, occasional explainers, and teases apart what's hype/ what's real -- as well as where we are on the long arc of innovation: #1 Hackers spied on U.S. Treasury emails and other federal agencies through malware installed (indirectly via a third-party provider) over a year ago, but the hack was just revealed this weekend and confirmed in a statement from the National Security Council yesterday. It could be one of the largest (publicly disclosed) hacks of late, so former CSO and a16z operating partner for security Joel de la Garza shares the breaking news and developing story as well as where this fits in overall security trends -- with Sonal Chokshi. #2 The first of several planned Eth2 upgrades to Ethereum recently went live : the Beacon Chain. Given that DeFi (decentralized finance) and other decentralized applications are often in the headlines, and that Ethereum has experienced growing pains in the past, a16z crypto partner Ali Yahya breaks down what this is and why the news matters in the big picture -- with Zoran Basich. Views expressed in “posts” (including podcasts, videos, and social media) are those of the individual a16z personnel quoted therein and are not the views of AH Capital Management, L.L.C. (“a16z”) or its respective affiliates. AH Capital Management is an investment adviser registered with the Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. The posts are not directed to any investors or potential investors, and do not constitute an offer to sell -- or a solicitation of an offer to buy -- any securities, and may not be used or relied upon in evaluating the merits of any investment. The contents in here -- and available on any associated distribution platforms and any public a16z online social media accounts, platforms, and sites (collectively, “content distribution outlets”) -- should not be construed as or relied upon in any manner as investment, legal, tax, or other advice. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment. Any projections, estimates, forecasts, targets, prospects and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any charts provided here or on a16z content distribution outlets are for informational purposes only, and should not be relied upon when making any investment decision. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, posts may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. All content speaks only as of the date indicated. Under no circumstances should any posts or other information provided on this website -- or on associated content distribution outlets -- be construed as an offer soliciting the purchase or sale of any security or interest in any pooled investment vehicle sponsored, discussed, or mentioned by a16z personnel. Nor should it be construed as an offer to provide investment advisory services; an offer to invest in an a16z-managed pooled investment vehicle will be made separately and only by means of the confidential offering documents of the specific pooled investment vehicles -- which should be read in their entirety, and only to those who, among other requirements, meet certain qualifications under federal securities laws. Such investors, defined as accredited investors and qualified purchasers, are generally deemed capable of evaluating the merits and risks of prospective investments and financial matters. There can be no assurances that a16z’s investment objectives will be achieved or investment strategies will be successful. Any investment in a vehicle managed by a16z involves a high degree of risk including the risk that the entire amount invested is lost. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. Past results of Andreessen Horowitz’s investments, pooled investment vehicles, or investment strategies are not necessarily indicative of future results. A list of investments made by funds managed by a16z is available here: https://a16z.com/investments/. Excluded from this list are investments (and certain publicly traded cryptocurrencies/ digital assets) for which the issuer has not provided permission for a16z to disclose publicly. As for its investments in any cryptocurrency or token project, a16z is acting in its own financial interest, not necessarily in the interests of other token holders. a16z has no special role in any of these projects or power over their management. a16z does not undertake to continue to have any involvement in these projects other than as an investor and token holder, and other token holders should not expect that it will or rely on it to have any particular involvement. For other site terms of use, please go here . Additional important information about a16z, including our Form ADV Part 2A Brochure, is available at the SEC’s website, http://www.adviserinfo.sec.gov .0 comments0
- AlphaFold! Protein Folding, Beyond the HypeIn this episode of our show 16 Minutes -- where we talk about the headlines, and where we are on the long arc of tech trends -- we cover the news around Google DeepMind's AlphaFold system for predicting the 3-D structure of proteins outperforming 100 teams across 20 countries in the 14th Community Wide Assessment on the CASP (Critical Assessment of Structure Prediction) challenge. The challenge, which takes place every other year (over several months) tracks progress, key metrics, and state-of-the-art on predictive techniques for protein folding. This isn’t just an academic challenge; it matters because proteins define and power ALL life functions, and as the saying goes, “structure is function”: Figuring out the shapes that proteins assemble into is important in helping determine their functions and therefore potential applications (drug discovery, among other things). However, the astronomical number of possible structures for proteins -- and difficulty of figuring out these out (whether experimentally or computationally) from their amino-acid sequences alone -- has made it one of the grand challenges in biology. Some of the older techniques are described as "kind of like making a finger puppet to cast a shadow, and then trying to figure out what your fingers were like from the shadow"... So is this grand protein folding problem really solved? Will it really revolutionize drug discovery? What's hype/ what's real when it comes to the buzz here; what are other applications; and what are the implications for open science, molecular biologists, computer scientists; big companies, startups? General partner Vijay Pande -- formerly professor of chemistry and structural biology and computer science, among other things at Stanford -- also founded the Folding@home project (which pioneered using distributed computing to solve the protein folding problem) and chats with Sonal Chokshi about whether this is a breakthrough or not. What is it, and where are we, really... ImageNet moment? E-MC2? Internet 1.0? Woodstock?! other sources " ‘It will change everything’: DeepMind’s AI makes gigantic leap in solving protein structures", Ewen Callaway, Nature, 30 November 2020 " ‘The game has changed.’ AI triumphs at solving protein structures", Robert Service, Science magazine, 30 November 2020 " DeepMind’s protein-folding AI has solved a 50-year-old grand challenge of biology", Will Heaven, Technology Review, 30 November 2020 images/ source: median accuracy in free-modeling category over the past 14 years; two protein targets and AlphaFold predicted structures compared against experimental result, both from the free modeling category / DeepMind0 comments0
- Transparency in Pricing, Ruling Healthcare[simplecast-embed src="https://16minutes.simplecast.com/episodes/16mins-transparency-in-coverage-rules-cms-hhs-healthcare-pricing-cost-patients-payers-hospitals-comparison-competition?dark=true"] The Centers for Medicare & Medicaid Services (CMS) issued the latest in a series of “ historic" rules a few weeks ago; the controversial rules -- which have been in the works for a while, but are now final -- are intended to increase price transparency in (what's been described by the U.S. Department of Health and Human Services’ secretary as) a "shadowy system where prices are hidden". Specifically, the two rules will require hospitals, group health plans, and health insurance issuers to disclose price and cost-sharing information to participants, beneficiaries, and enrollees up front; give patients accurate estimates of the costs that they are responsible for, including making previously unavailable price information accessible to them and other stakeholders; and doing so in a standardized, machine-readable way that allows for easy comparisons (and therefore more choice and competition). So in this episode of 16 Minutes, a16z bio experts Justin Larkin and general partner Julie Yoo (who also interviewed Dr. Marty Makary, author of The Price We Pay, on a previous episode) join Sonal Chokshi to discuss the specifics of, and the impact of, the rules on consumers and on various industry players. As is the premise of the show, they also break down the gap between what's hype/ what's real when it comes to mandates and implementation; while the rules go into effect January 2021, the deadlines roll out through 2024. What are the tensions (and paradoxes!) between hospitals and insurers, between efficient markets and top-down policy, between price vs. cost, between planned vs. surprise costs, between shoppable and non-shoppable services, between price and quality, price and value? Where do incentives align (or not)? And what are the challenges, and opportunities, for builders?0 comments0
Podcast hosts
No host has claimed this podcast yet, if you are the host you can verify ownership by claiming this podcast
Keywords
© 2019 Andreessen Horowitz
